# DAPSONE
> **ANDA209890** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2023-10-19
## Drug
- **FDA Application Number:** ANDA209890
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DAPSONE
- **Generic name:** DAPSONE
- **Active ingredients:** DAPSONE
- **Dosage form:** GEL
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** AMNEAL
- **Manufacturer:** Amneal Pharmaceuticals LLC
- **First approval:** 2023-10-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209890)
---
*AI Analytics · CC0 1.0*